Similar Articles
461 Hepatocellular carcinoma and immunotherapy: Beyond immune checkpoint inhibitors
462 Hepatocellular carcinoma, hepatitis C virus infection and miRNA involvement: Perspectives for new therapeutic approaches
463 Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment
464 Rare case of hepatocellular carcinoma metastasis to urinary bladder: A case report
465 Radiomics for the detection of microvascular invasion in hepatocellular carcinoma
466 Future prospect of “Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients”
467 Role of hepatitis B virus in development of hepatocellular carcinoma: Focus on covalently closed circular DNA
468 Emerging curative-intent minimally-invasive therapies for hepatocellular carcinoma
469 Loco-regional treatment of hepatocellular carcinoma: Role of contrast-enhanced ultrasonography
470 Functions of three ubiquitin-conjugating enzyme 2 genes in hepatocellular carcinoma diagnosis and prognosis
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA